Your SlideShare is downloading. ×
0
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
randomized clinical trials II
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

randomized clinical trials II

556

Published on

Integrated Dentistry I …

Integrated Dentistry I
Third Year

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
556
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Randomized Controlled Trials Part 2
  • 2. Outcomes • • • • Identify the RCT study design Discuss the various characteristics of RCTs Describe measures of effectiveness in RCTs Identify tools of critical appraisal of RCTs
  • 3. Study Types MAIN TYPES OF STUDY DESIGN Crosssectional Retrospective Cohort Observational Longitudinal Study Design Prospective Cohort Experimental Case-control
  • 4. RCT Study Design Population sample Randomization & Allocation Concealment Intervention Disease Placebo NO Disease NO Disease Disease
  • 5. Characteristics of RCTs • • • • • • • • • Prospective: Eligibility criteria for participants Settings and locations Description of the interventions Defined pre-specified outcomes How sample size was determined Allocation Concealment Blinding Statistical methods
  • 6. Characteristics of RCTs Statistical methods used to compare groups • Intention-to-treat analysis Experimental (composite) Control (Amalgam) 100 100 20 ?? 80 8F 12 8/80 = 10% 100 72 S 8 20/100= 20% 20 F 80 S 20/100= 20%
  • 7. Characteristics of RCTs Statistical methods used to compare groups • Intention-to-treat analysis Experimental (composite) Control (Amalgam) 100 100 20 ?? 80 8F 20 28/100= 28% 100 72 S 20 F 80 S 20/100= 20%
  • 8. Characteristics of RCTs Statistical methods used to compare groups • Intention-to-treat analysis • Analysis by which all participants are included in the arm to which they were allocated, whether or not they received (or completed) the intervention given to that arm. • Intention-to-treat analysis prevents bias caused by the loss of participants
  • 9. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat – Risk Difference (Absolute Risk Reduction) • Relative Risk • Odds Ratio
  • 10. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What proportion had inflammation in GingiFree group? 4 out of 55 or 7.3% This is called: Experimental Event Rate (EER) or Risk
  • 11. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What proportion had inflammation in placebo group? 14 out of 52 or 26.9% This is called: Control Event Rate (CER) or Risk
  • 12. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What is the difference in risk of inflammation between the two groups? CER – EER = ARR (Absolute Risk Reduction) 26.9% - 7.3% = 19.6
  • 13. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 How many people do you need to treat with GingiFree to prevent 1 additional inflammation? Number Needed to Treat (NNT) 1 / ARR
  • 14. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 How many people do you need to treat with GingiFree to prevent 1 additional inflammation? Number Needed to Treat (NNT) = 1/ARR 1 / 19.6 = 5.1
  • 15. Characteristics of RCTs Statistical methods used to compare groups 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What is the risk of developing inflammation in the experimental group relative to the control group? EER/CER = Relative Risk (Risk Ratio) 7.3/ 26.9 = 0.27
  • 16. Characteristics of RCTs Statistical methods used to compare groups 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What is the Odds Ratio of the study? Odds = 4/51 = 0.078 and 14/38 = 0.368 Odds Ratio = Odds of exp/Odds of control = 0.078/0.368 = 0.21
  • 17. Critical Appraisal of the Evidence • What are the results? – How large was the treatment effect? • Relative risk, mean difference, etc. – How precise was the estimate of the treatment effect? • Confidence intervals
  • 18. Critical Appraisal of the Evidence • Can I apply the results locally? – Can the results be applied to my patients? – Were all clinically important outcomes considered? – Are the likely treatment benefits worth the potential harms and costs?
  • 19. The Basics of Critical Appraisal Critical Appraisal of RCTs Randomization The process of randomly allocating participants into one of the arms of a controlled trial. - tossing a coin - computer generated tables It assures: all factors are equal less bias in patient selection
  • 20. The Basics of Critical Appraisal Critical Appraisal of RCTs Randomization Allocation concealment The process of preventing foreknowledge of group assignment in a randomized controlled trial. The most common method of concealment is the use of opaque, sealed envelopes.
  • 21. The Basics of Critical Appraisal Critical Appraisal of RCTs Randomization Allocation concealment Blinding The process of preventing those involved in a trial from knowing to which comparison group a particular participant belongs.
  • 22. The Basics of Critical Appraisal Critical Appraisal of RCTs Randomization Allocation concealment Blinding Intention to treat analysis Analysis by which all participants are included in the arm to which they were allocated, whether or not they received (or completed) the intervention given to that arm. Intention-to-treat analysis prevents bias caused by the loss of participants
  • 23. The Basics of Critical Appraisal Critical Appraisal of RCTs 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What is the odds of inflammation in the GingiFree group relative to placebo? Odds 4/51= 0.07 14/38=0.37 Odds Ratio = 0.07/ 0.37= 0.23

×